Skip to content

2024 July 11 release
Compare
Choose a tag to compare
@brendanreardon brendanreardon released this 11 Jul 14:50
· 6 commits to main since this release
v.2024-07-11
736decd
This commit was created on GitHub.com and signed with GitHub’s verified signature.
GPG key ID: B5690EEEBB952194
Learn about vigilant mode.

Added entries:

  • (FDA) KRAS p.G12C and sensitivity to adagrasib in combination with cetuximab for patients with colorectal cancer received accelerated approval.
  • (FDA) NTRK1/2/3 gene fusions and sensitivity to repotrectinib for patients with solid tumors received accelerated approval.

Revised entries:

  • (FDA) RET fusions and sensitivity to selpercatinib for patients with thyroid cancer received traditional approval from the FDA, from accelerated approval.
Assets 2
Loading